AN2 Therapeutics, Inc. (ANTX)

3.61 +0.47 (+14.97%) USD  |  NASDAQ  |  Apr 17, 16:00
3.62 +0.01 (+0.28%) After-Hours: 20:00
More

AN2 Therapeutics Free Cash Flow Per Share (Quarterly)

Free Cash Flow Per Share (Quarterly) Chart

View Free Cash Flow Per Share (Quarterly) for ANTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Per Share (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Per Share (Quarterly) Range, Past 5 Years

View Free Cash Flow Per Share (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Per Share (Quarterly) Benchmarks

View Free Cash Flow Per Share (Quarterly) Benchmarks
Start Trial
Relmada Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade

Free Cash Flow Per Share (Quarterly) Related Metrics

Cash from Operations (Quarterly) Upgrade
Cash from Investing (Quarterly) Upgrade
Free Cash Flow Upgrade
Free Cash Flow to Equity (Quarterly) Upgrade
Free Cash Flow to Firm (Quarterly) Upgrade
Free Cash Flow Yield Upgrade